Phase 1 Diabetic Kidney Disease Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients

Diabetic Kidney Disease

Alebund Pharmaceuticals18 enrolled1 locationNCT06666283

Recruiting

Phase 1

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

Cardiovascular DiseasesEndothelial DysfunctionType 1 Diabetes+2 more

Kalie Tommerdahl60 enrolled2 locationsNCT05065372

Recruiting

Phase 1

Dosimetry of Tc-99m-Tilmanocept

Diabetic Kidney Disease

University of California, San Diego120 enrolled1 locationNCT05241522